The global animal genetics market is exploding, projected to reach USD 12.11 billion by 2034 (Animal Genetics Market Forecast 2025-2034) as pandemics and climate crises push biotech innovation into overdrive. From avian flu outbreaks to foot-and-mouth scares, labs like the UK's Animal and Plant Health Agency (APHA) are racing to decode pathogens faster than they mutate. As experts note, "The stakes have never been higher, and the innovations coming out now are nothing short of revolutionary."

The Sequencing Arms Race

Biovenic plays the role as a genomics heavyweight betting big on three "next-gen weapons" for the animal health arena:

Animal De Novo Sequencing
Dubbed the "Sherlock Holmes of pathogens", this technology involves sample quality control, library construction, sequencing, data quality control, and bioinformatics analysis, thus allowing researchers to obtain animal species reference sequence for origin studies, evolution tracing, or database setup. "We're building a genetic fingerprint database for every critter from alpacas to zebra mussels," says a scientist at Biovenic, citing its 50% faster outbreak tracing versus legacy PCR methods.

Animal Whole-Genome Sequencing
Biovenic provides a technical WGS solution covering the entire sample and library preparation, sequencing, data quality control, and bioinformatics analysis, to accurately obtain an animal's complete genetic profile at the single nucleotide level and help identify genomic variants like SNPs, InDel, CNV, and SV.

Animal Targeted Sequencing
Biovenic manages multiplex amplicon sequencing and hybrid capture sequencing platforms for animal target regions and conducts material selection, library construction, sequencing, and data analysis. "Our sequencing process is efficient and fast, increasing research efficiency and reducing costs when studying specific regions within the genome."

In summary, the dynamic interplay between innovative sequencing technologies and robust market growth is setting the stage for a revolution in animal health research. With Biovenic at the forefront, employing services that range from de novo to whole-genome and targeted sequencing, animal disease detection and management looks brighter than before. "The fusion of state-of-the-art science with real-world applications is a testament to how far we've come—and a sneak peek into the game-changing advances just around the corner." The scientist says.

About
Biovenic has launched advanced technology platforms for animal-related research and development, providing global researchers with a variety of animal breeding and genetic research solutions for different project goals.